ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Sep 19, 2013
Insider Transaction Report
Form 4
Woosley Raymond L.
Director
Transactions
- Award
Stock Option (right to buy)
2013-09-17+14,750→ 14,750 totalExercise: $1.38Exp: 2023-09-17→ Common Stock (14,750 underlying) - Award
Stock Option (right to buy)
2013-09-17+3,463→ 3,463 totalExercise: $1.38Exp: 2023-09-17→ Common Stock (3,463 underlying)
Footnotes (2)
- [F1]Grant to the Reporting Person of a stock option under the 2013 Equity Incentive Plan, vesting in 36 equal monthly installments beginning as of July 26, 2013.
- [F2]Grant to the Reporting Person of a stock option under the 2013 Equity Incentive Plan, vesting in five equal monthly installments beginning as of July 26, 2013.